4//SEC Filing
ATOSSA GENETICS INC 4
Accession 0001144204-16-083010
$ATOSCIK 0001488039operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 3:03 PM ET
Size
5.3 KB
Accession
0001144204-16-083010
Insider Transaction Report
Form 4
Chen Shu-Chih
DirectorChief Scientific Officer10% Owner
Transactions
- Purchase
Common Stock
2016-02-16$0.53/sh+15,000$7,950→ 4,333,315 total(indirect: See Footnote)
Footnotes (2)
- [F1]Represents 15,000 shares purchased in an at-market transaction directly from Atossa Genetics, Inc.
- [F2]Consists of 4,333,315 shares of common stock owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity.
Documents
Issuer
ATOSSA GENETICS INC
CIK 0001488039
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001488039
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 3:03 PM ET
- Size
- 5.3 KB